HRTX Dec 2024 4.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.8000

+0.0500

(+6.67%)

As of 09:55AM EDT. Market open.

Loading interactive chart…

Zacks
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Data from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.
Zacks
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Here is how CareCloud, Inc. (CCLD) and Heron Therapeutics (HRTX) have performed compared to their sector so far this year.
Zacks
5 Small Drug Stocks to Buy From a Recovering Industry
Innovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX, BVS, AQST, ACRV and CRDL may prove to be good additions to one's portfolio.